Find a Tender
complete
Official procurement procedure
ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack
Medical equipments
pharmaceuticals and personal care products
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: BELFAST HEALTH AND SOCIAL CARE TRUST: "ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | BELFAST HEALTH AND SOCIAL CARE TRUST | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: BELFAST HEALTH AND SOCIAL CARE TRUST
Market Analytics
Derived from OCDS awards & bid statistics
Published history for BELFAST HEALTH AND SOCIAL CARE TRUST. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
1Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 240 active published awards; 229 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityBELFAST HEALTH AND SOCIAL CARE TRUST | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published5 Jan 2024, 09:54 GMT | Last source update5 Jan 2024, 09:54 GMT | Recurring procurementNot published |
ClassificationMedical equipments, pharmaceuticals and personal care products | ||
Delivery area | ||
OCIDocds-h6vhtk-042ad7 | ||
What is being bought
Procurement of ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack
What changed
From the official release history
- Status changed to complete
5 Jan 2024, 09:54 GMT - Official notice release published
5 Jan 2024, 09:54 GMT - Buyer information updated
5 Jan 2024, 09:54 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedProcurement of ENCORAFENIB 75 mg Hard Capsules 42 Capsule PackContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
5 Jan 2024, 09:54 GMT - Award active
Not published · Not published - Contract active
Signed 20 Dec 2023, 00:00 GMT · £900,000
Commercial outcome and competition
Awards PIERRE FABRE LIMITED Not published · Not published · active |
Contracts ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack £900,000 · signed 20 Dec 2023, 00:00 GMT · active |
Bid statistics bids: 1 (lot 1) |
Buyer and organisations in this procedure
BELFAST HEALTH AND SOCIAL CARE TRUST
Contracting authority GB-FTS-4486Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThese are branded patent protected medicines that are essential to patient care and are available from only one economic operator. BHSCT can confirm that the absence of competition is not a result of the artificial narrowing of the parameters of the procurement. |